Search

Your search keyword '"Cyanosis metabolism"' showing total 72 results

Search Constraints

Start Over You searched for: Descriptor "Cyanosis metabolism" Remove constraint Descriptor: "Cyanosis metabolism"
72 results on '"Cyanosis metabolism"'

Search Results

1. Sex differences in metabolic adaptation in infants with cyanotic congenital heart disease.

2. Differences in the serum metabolic profile to identify potential biomarkers for cyanotic versus acyanotic heart disease.

3. First Observation of HbM-Saskatoon at the Origin of Neonatal Cyanosis in a Tunisian Baby.

4. Chronic perinatal hypoxia delays cardiac maturation in a mouse model for cyanotic congenital heart disease.

5. Knockdown of Long Noncoding RNA SNHG14 Protects H9c2 Cells Against Hypoxia-induced Injury by Modulating miR-25-3p/KLF4 Axis in Vitro.

6. Fractional exhaled nitric oxide in adult congenital heart disease.

7. Hypoxia induces senescence of bone marrow mesenchymal stem cells via altered gut microbiota.

8. NEU3 sialidase role in activating HIF-1α in response to chronic hypoxia in cyanotic congenital heart patients.

9. Alterations in antioxidant and oxidant status of children after on-pump surgery for cyanotic and acyanotic congenital heart diseases.

10. Effects of hypoxia and its relationship with apoptosis, stem cells, and angiogenesis on the thymus of children with congenital heart defects: a morphological and immunohistochemical study.

11. Apelin receptor (APJ) expression during cardiopulmonary bypass in children undergoing surgical repair.

12. Limitations of cerebral oxygenation monitoring by near-infrared spectroscopy in children with cyanotic congenital heart disease and profound polycythemia.

13. A new (G)γ-globin variant causing low oxygen affinity: Hb F-Brugine/Feldkirch [(G)γ105(G7)Leu→His; HBG2: c.317T>A].

14. miR-138 protects cardiomyocytes from hypoxia-induced apoptosis via MLK3/JNK/c-jun pathway.

15. Heat shock protein 27 is increased in cyanotic tetralogy of Fallot myocardium and is associated with improved cardiac output and contraction.

16. Correlation of a novel noninvasive tissue oxygen saturation monitor to serum central venous oxygen saturation in pediatric patients with postoperative congenital cyanotic heart disease.

17. Surgical reoxygenation injury of the myocardium in cyanotic patients: clinical relevance and therapeutic strategies by normoxic management during cardiopulmonary bypass.

18. Neonatal cyanosis due to a new (G)γ-globin variant causing low oxygen affinity: Hb F-Sarajevo [(G)γ102(G4)Asn→Thr, AAC>ACC].

19. Impact of chronic cyanosis and reoxygenation on the microheterogeneity of the myocardial blood flow: digital radiographic study in neonatal rats.

20. Cyanosis.

21. Expression of ghrelin and insulin-like growth factor-1 in immature piglet model of chronic cyanotic congenital heart defects with decreased pulmonary blood flow.

22. Myocardial expression of heat shock protein 70i protects early postoperative right ventricular function in cyanotic tetralogy of Fallot.

24. Cyanosis by methemoglobinemia in tadpoles of Cochranella granulosa (Anura: Centrolenidae).

25. Tolerance of the developing cyanotic heart to ischemia-reperfusion injury in the rat.

26. Metabolic characteristics of immature myocardium.

27. Serum levels of ghrelin, tumor necrosis factor-alpha and interleukin-6 in infants and children with congenital heart disease.

28. Age-dependent vulnerability to ischemia-reperfusion injury of cyanotic myocardium in a chronic hypoxic rat model.

29. The levels of Ghrelin, TNF-alpha, and IL-6 in children with cyanotic and acyanotic congenital heart disease.

30. Changes in myocardial free amino acids during pediatric cardiac surgery: a randomised controlled trial of three cardioplegic techniques.

31. Measurement of cerebral-oxygenation status when commencing cardiopulmonary bypass in pediatric open-heart surgery.

32. Free amino acids in hearts of pediatric patients with congenital heart disease: the effects of cyanosis, age, and pathology.

33. Gene targeting reveals a widespread role for the high-mobility-group transcription factor Sox11 in tissue remodeling.

34. The origin of hydrogen sulfide in a newborn with sulfhaemoglobin induced cyanosis.

35. Does normoxemic cardiopulmonary bypass prevent myocardial reoxygenation injury in cyanotic children?

36. Does the degree of cyanosis affect myocardial adenosine triphosphate levels and function in children undergoing surgical procedures for congenital heart disease?

37. Myocardial aerobic metabolism is impaired in a cell culture model of cyanotic heart disease.

38. [The nutritional status of the child with congenital cardiopathy].

39. Use of an adjustable tourniquet to reverse cyanosis in the newborn pig.

40. Oxygen supply during cardiopulmonary bypass (CPB) in cyanotic patients.

41. The effects of cyanosis on myocardial blood flow, oxygen utilization, and lactate production in dogs.

42. Pharmacokinetics of alcuronium in children with acyanotic and cyanotic cardiac disease undergoing cardiopulmonary bypass surgery.

43. Encephalopathy, petechiae, and acrocyanosis with ethylmalonic aciduria associated with muscle cytochrome c oxidase deficiency.

44. Monitoring of tissue oxygenation via parameters of erythropoetic activity.

45. Abnormalities in skeletal muscle metabolism in cyanotic patients with congenital heart disease: a 31P nuclear magnetic resonance spectroscopy study.

46. Metabolic effects of corrective surgery in infants and children with congenital heart defects.

47. Regulation of atrial autonomic receptors in experimental cyanotic heart disease.

48. Myocardial beta-adrenoceptor density and the distribution of beta 1- and beta 2-adrenoceptor subpopulations in children with congenital heart disease.

49. Differential regulation of right and left ventricular beta-adrenergic receptors in newborn lambs with experimental cyanotic heart disease.

50. Oxygen consumption and evaporative water loss in infants with congenital heart disease.

Catalog

Books, media, physical & digital resources